Contagion®

@contagionlive.bsky.social

Providing timely news to improve the diagnosis, treatment, and prevention of infectious diseases. Read our coverage: contagionlive.com

The FDA is now reporting this on the Taylor Farms samples: "Due to the complexity in detection of Cyclospora, FDA laboratory experts re-reviewed the sample results and have concluded that the finding does not represent true amplification and should be considered a false positive."

The Latest on the Cyclosporiasis Outbreak: An FDA False Positive Test, and What Treatment Looks Like | Contagion Live

The source of the outbreak has been determined and Catherine O’Neal, MD, offers insights on key symptoms that warrant medical evaluation, and what medical treatment may consist of for those being seen...

contagionlive.com

Island Pharmaceuticals is leveraging the WHO's MEURI framework alongside the FDA Animal Rule pathway to evaluate investigational antiviral, #galidesivir, during Africa's Bundibugyo #Ebola outbreak while advancing regulatory development for a potential broad-spectrum filovirus therapy. #IDsky

Antiviral Being Used in Current Ebola Outbreak Advances Through Dual Development Strategy | Contagion Live

Island Pharmaceuticals is leveraging the WHO's MEURI framework alongside the FDA Animal Rule pathway to evaluate investigational antiviral, galidesivir, during Africa's Bundibugyo Ebola outbreak while...

contagionlive.com

The CDC has identified 843 domestically acquired #cyclosporiasis cases across 31 states as of Thursday, with investigators continuing to examine multiple multistate clusters and potential food sources. Separately, but related, the state of Michigan reported 1,562 confirmed cases.

Cases of Cyclosporiasis Continue to Rise Across 31 States With Michigan Reporting Highest Numbers | Contagion Live

The CDC has identified 843 domestically acquired #cyclosporiasis cases across 31 states as of Thursday, with investigators continuing to examine multiple multistate clusters and potential food sources...

contagionlive.com

This week, read about how laboratory antimicrobial susceptibility results may not predict clinical outcomes, watch a clinician discuss the DOTS and PETERPEN trials, the FDA has granted Priority Review to expand dolutegravir use to newborns with HIV, and more. www.contagionlive.com/view/top-inf...

Top Infectious Disease News Stories Week of July 5- July 11 | Contagion Live

This week, read about how laboratory antimicrobial susceptibility results may not predict clinical outcomes, watch a clinician discuss the DOTS and PETERPEN trials, the FDA has granted Priority Review...

contagionlive.com

New research suggests that bacterial responses to antibiotics vary significantly under nutrient-limited conditions, highlighting potential limitations of standard laboratory susceptibility testing and offering new insights into why some laboratory findings fail to predict clinical outcomes.

Nutrient-Limited Conditions May Dramatically Alter Antibiotic Effectiveness | Contagion Live

New research from Rutgers University suggests that bacterial responses to antibiotics vary significantly under nutrient-limited conditions, highlighting potential limitations of standard laboratory su...

contagionlive.com